HPV Vaccine for Adult Men: Is 30, 40, or 45 Too Late?
The HPV vaccine (Gardasil 9) is FDA-approved for men through age 45. Between 27 and 45, vaccination is recommended after a shared decision with your clinician, because most benefit accrues in men not yet exposed to all 9 vaccine-covered strains. Efficacy against persistent infection with covered types exceeds 90 percent in unexposed adults and remains meaningful after exposure to one or two strains. Vaccination is often given off-label after 45 in immunocompromised patients or those with recurrent warts. Standard adult schedule is 3 doses over 6 months.
The old advice that the HPV vaccine was only worthwhile before age 26 has been outdated since 2018, when the FDA extended Gardasil 9 up to age 45 in both sexes. Yet many primary care doctors still tell adult men they have missed the window. That is wrong, and it costs patients years of preventable disease including genital warts, penile cancer, anal cancer, and the fastest-rising HPV cancer of all — oropharyngeal (throat) cancer in men.
This guide walks through who benefits from adult HPV vaccination, what the evidence actually shows for men aged 27 to 45, what happens if you get it after 45, dosing schedules, side effects, cost in Turkey versus the UK, US, and Germany, and whether you should still get vaccinated if you already have genital warts.
Key takeaways
- Gardasil 9 is FDA-approved for men from age 9 to 45. Europe follows similar guidance.
- Efficacy is highest in men not yet sexually active but is still 40–70 percent for previously exposed adults, because the vaccine covers 9 strains and you are unlikely to have encountered all of them.
- Adult schedule (age 15+): three doses at 0, 2, and 6 months.
- Off-label use after 45 is reasonable in immunocompromised patients and in men with recurrent warts.
- Cost in Turkey: roughly USD 180–260 per dose. In the US: USD 250–330 per dose. Insurance coverage varies by country and age.
What Gardasil 9 protects against
Gardasil 9 is a recombinant, non-infectious vaccine containing virus-like particles from 9 HPV types:
Our full clinical protocol is on the HPV and genital wart treatment for men page.
- Low-risk types (wart-causing): 6 and 11 — responsible for around 90 percent of genital warts
- High-risk types (cancer-causing): 16, 18, 31, 33, 45, 52, and 58 — together responsible for around 90 percent of HPV-driven cancers globally, including the majority of penile, anal, and oropharyngeal cancers
The vaccine does not contain any live virus. It trains the immune system to produce neutralising antibodies that block HPV before it enters basal keratinocytes.
Age limits: what the FDA, WHO, and EMA say
| Body | Approved for men age | Notes |
|---|---|---|
| FDA (US) | 9–45 | Extended from 26 in 2018 |
| ACIP / CDC (US) | Routine 11–12, catch-up 13–26, shared decision 27–45 | Not universally recommended after 26 |
| EMA (EU) | 9+ (no upper limit specified for Gardasil 9) | Country programmes vary |
| WHO | Primarily 9–14 (girls), catch-up to 26; broader access encouraged | Programme focus is cervical cancer elimination |
| Turkey (Ministry of Health) | Available privately; not on the national schedule | Sold on prescription in private pharmacies |
Why the age limit was extended to 45
The 2018 FDA expansion was based on Phase III trial data (V503-006, the “Mid-Adult Women” trial and its male counterpart) showing that Gardasil 9 was safe and immunogenic in adults aged 27 to 45 and reduced persistent infection with vaccine-covered types. The extension reflected the reality that many adults have new partners after 26 and continue to acquire new HPV strains throughout life.
Anatomical length or girth is a separate procedure — details on our penis enlargement surgery page.
How much benefit for men aged 27–45?
The honest answer is nuanced. A man of 35 has probably been exposed to 1 to 3 HPV strains but not all 9 covered by Gardasil 9. Vaccination cannot cure an existing infection with a strain you have already met, but it fully protects against the other 6 to 8 strains you have not yet met. Modelling studies estimate that vaccination between 27 and 45 prevents roughly 30–70 percent of new HPV-related lesions over the following decade, with the higher end applying to men with fewer prior sexual partners.
An office-based option worth mentioning is glans (penis head) filler for premature ejaculation.
Vaccination if you already have HPV or warts
Vaccination is still worthwhile for these patients. Two reasons:
A nerve-targeted alternative when medication fails is selective dorsal cryoablation for premature ejaculation.
- You are almost certainly infected with 1 or 2 HPV types, not all 9. Vaccination protects against the strains you have not yet encountered.
- Post-treatment vaccination reduces recurrence of genital warts by roughly 35 percent in observational studies, likely by boosting immune surveillance against low-level viral reservoirs.
Read more about our combined HPV treatment programme and genital wart treatment which includes vaccination discussion for every patient.
Off-label vaccination after 45
The FDA label stops at 45 because that was the upper age of the clinical trials, not because efficacy suddenly drops. There is no biological reason vaccine antibodies would fail to work in a 50-year-old. Off-label vaccination is common in the following groups:
Because signs are often silent, review HPV in men: symptoms and warning signs.
- Men with recurrent genital warts
- HIV-positive men and other immunocompromised patients
- Men with a new sexual partner after divorce or bereavement
- Men with a spouse newly diagnosed with cervical HPV or dysplasia
Off-label prescriptions are legal and clinically reasonable but usually out of pocket, since insurance rarely reimburses beyond the licensed age.
Immunocompromised men
HIV-positive men, transplant recipients, and men on long-term immunosuppressive therapy are at markedly higher risk of persistent HPV, recurrent warts, anal dysplasia, and anal cancer. All major guidelines recommend HPV vaccination in this group regardless of age, using the 3-dose schedule.
Considering the HPV vaccine but not sure whether it is worth it for your age?
Dosing schedule for adults
| Age at first dose | Schedule | Doses |
|---|---|---|
| 9–14 years | 0 and 6–12 months | 2 |
| 15+ years (including all adults) | 0, 2, and 6 months | 3 |
| Immunocompromised (any age) | 0, 2, and 6 months | 3 |
Missed doses do not require restarting the series; continue from where you left off. Minimum intervals are 4 weeks between dose 1 and 2, 12 weeks between dose 2 and 3, and 5 months from dose 1 to dose 3.
For every method ranked, see genital warts treatment for men.
Side effects and safety data
Gardasil 9 has one of the largest post-marketing safety datasets of any modern vaccine — over 270 million doses distributed globally. The vast majority of side effects are local and mild.
When timing matters, read how to get rid of genital warts fast.
- Very common (>10%): injection-site pain, swelling, redness; headache
- Common (1–10%): low-grade fever, fatigue, muscle ache, nausea
- Uncommon: dizziness, syncope (fainting, usually vasovagal — patients should sit for 15 minutes after)
- Rare: allergic reaction (anaphylaxis roughly 1 in 100,000 doses)
No causal link has been established with autoimmune disease, POTS, chronic fatigue, or infertility despite intense scrutiny; multiple large studies have confirmed the safety profile.
Cost and availability in Turkey vs abroad
| Country | Cost per dose (private) | Total 3-dose series | Insurance |
|---|---|---|---|
| Turkey | USD 180–260 | USD 540–780 | Not on national programme; private only |
| USA | USD 250–330 | USD 750–990 | Usually covered under 26; variable 27–45 |
| UK | GBP 150–200 | GBP 450–600 | NHS covers boys under 25 and MSM under 45 |
| Germany | EUR 160–220 | EUR 480–660 | Statutory insurance covers under 18; adult self-pay |
| UAE | AED 900–1,300 | AED 2,700–3,900 | Some private insurance |
Availability in Turkey has been consistent through licensed private pharmacies and clinics. International patients often combine a first vaccine dose with a wart-treatment visit in Istanbul, then complete the series at home.
Foreskin considerations are covered in our adult circumcision guide.
Combining vaccination with wart treatment
A typical protocol I use:
Curvature (Peyronie’s) has its own ladder — see Peyronie’s disease treatment.
- Day 0: full HPV assessment plus CO2 laser ablation of any visible warts under local anaesthesia
- Same visit: Gardasil 9 dose 1 in the deltoid
- Day 10 onwards: begin imiquimod 5% three nights per week for 8–12 weeks
- Week 8: Gardasil 9 dose 2
- Month 6: Gardasil 9 dose 3, plus final clinical review
This bundles treatment, prevention, and follow-up into one 6-month plan.
Doctor’s perspective — Op. Dr. Cem İpek
The most common myth I dispel in clinic is that the HPV vaccine is only for teenage girls. It is licensed for men up to 45, it prevents genital warts, penile cancer, anal cancer, and throat cancer, and it works whether or not you already have HPV in your system, because it covers nine strains and you have almost certainly only met one or two of them.
The best time to vaccinate a man is before his first sexual partner. The second-best time is today. I have vaccinated men in their fifties, particularly those recovering from divorce, those with newly diagnosed partner HPV, and those with recurrent warts. None have regretted it.
The safety data is now enormous. Over a quarter of a billion doses have been given globally with an extremely reassuring profile. Sore arm and mild fatigue for a day are typical. Serious reactions are rarer than for many everyday medications people take without a second thought.
When to see a urologist
Book an appointment if any of the following applies:
- You are between 27 and 45 and unvaccinated
- You are over 45 and have recurrent genital warts or a new partner exposure
- You are HIV-positive, on immunosuppressive therapy, or a transplant recipient
- Your partner has tested positive for HPV or been diagnosed with cervical dysplasia
- You want to combine vaccination with wart treatment in a single 6-month plan
- Your primary care doctor has told you it is “too late” and you want a second opinion
Ready to protect yourself from HPV?
Book Gardasil 9 vaccination and (if needed) combined wart treatment at Androaesthe Istanbul.
Frequently asked questions
Is 40 too old for the HPV vaccine?
No. Gardasil 9 is FDA-approved for adult men up to age 45. Vaccination between 27 and 45 is recommended after a shared decision with your clinician; men who have not yet been exposed to all 9 covered strains still gain meaningful protection, particularly against the strains behind penile, anal, and oropharyngeal cancer.
Can I get the HPV vaccine after 45?
Yes, off-label. There is no biological cliff at 45; the label reflects the upper age of the clinical trials, not efficacy loss. Off-label vaccination is commonly offered to immunocompromised patients, men with recurrent warts, and men with new partner exposures. Cost is typically out of pocket.
Is the HPV vaccine effective if I already have HPV?
Yes, for the strains you have not yet encountered. Gardasil 9 covers 9 HPV types; you are unlikely to have met all of them. Vaccination also reduces recurrence of genital warts by roughly 35 percent in observational studies after treatment.
How many doses of Gardasil 9 do adults need?
Adults aged 15 and older need 3 doses given at 0, 2, and 6 months. Doses do not need to be restarted if delayed; the schedule continues from where it stopped, respecting minimum intervals.
What are the side effects of the HPV vaccine in adult men?
The most common are injection-site pain, swelling, and a low-grade fever or fatigue for a day or two. Fainting immediately after injection is uncommon but not rare; patients are asked to sit for 15 minutes. Serious reactions are very rare (anaphylaxis approximately 1 in 100,000 doses).
How much does Gardasil 9 cost in Turkey?
Approximately USD 180 to 260 per dose in private pharmacies and clinics, so USD 540 to 780 for the full 3-dose series. International patients often start the series in Istanbul during a wart treatment visit and complete it at home.
Should men with genital warts get the HPV vaccine?
Yes. Vaccination after treatment reduces recurrence by roughly 35 percent and protects against HPV strains not yet encountered, including the high-risk types responsible for penile, anal, and oropharyngeal cancer.
Does the HPV vaccine prevent cancer in men?
The vaccine prevents infection with the HPV types responsible for the majority of penile, anal, and oropharyngeal cancers. Long-term surveillance shows dramatic reductions in HPV-related lesions in vaccinated populations; direct cancer-endpoint data continues to accumulate as vaccinated cohorts age.
- FDA. Gardasil 9 Prescribing Information, current label with expansion to age 45 (2018).
- CDC. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR. 2019.
- WHO position paper on Human Papillomavirus vaccines, 2022 update.
- Joura EA et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. PMID: 25693011.
- Castellsagué X et al. Immunogenicity and safety of the 9-valent HPV vaccine in men. Vaccine. PMID: 26212007.
- European Association of Urology (EAU) Guidelines on Sexually Transmitted Infections, 2024 edition.



